Evidence map›Paper›PMID 33741975›Full record

ArticleNature communications2021

Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites.

Gaoqian Feng, Bruce D Wines, Liriye Kurtovic, Jo-Anne Chan, Philippe Boeuf, Vanessa Mollard, Anton Cozijnsen, Damien R Drew, Rob J Center, Daniel L Marshall and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Protective near-germline antibodies to malaria elicited by RTS,S/AS01bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Effect of periostin (OSF-2) on phagocytosis ofFrontiers in microbiology · 2025
    Article
  19. Review
  20. Development of high affinity antibodies toFrontiers in immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 3 countries.

Gaoqian FengBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.ORCID 0000-0002-3605-038X
Bruce D WinesBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.ORCID 0000-0002-4108-375X
Liriye KurtovicBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
Jo-Anne ChanBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.ORCID 0000-0003-0708-8263
Philippe BoeufBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
Vanessa MollardSchool of BioSciences, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0001-9222-8229
Anton CozijnsenSchool of BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
Damien R DrewBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
Rob J CenterBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
Daniel L MarshallBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
Sandra ChishimbaBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.ORCID 0000-0003-3987-5229
Geoffrey I McFaddenSchool of BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
Arlene E DentCentre for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
Kiprotich ChelimoDepartment of Biomedical Science and Technology, Maseno University, Kisumu, Kenya.
Michelle J BoyleBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.ORCID 0000-0002-0268-232X
James W KazuraCentre for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
P Mark HogarthBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
James G BeesonBurnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia. beeson@burnet.edu.au.ORCID 0000-0002-1018-7898
Burnet Institute · AUThe University of Melbourne · AUMaseno University · KE

Funding

Vector Biology of Invasive Anopheles stephensi in Rural to Urban Landscapes in EthiopiaU19AI129326 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Guiyun Yan · 2017 to 2026
$19.9M
NIAID NIH HHS U19 AI129326
6 · The paper itself

Abstract

A highly protective vaccine will greatly facilitate achieving and sustaining malaria elimination. Understanding mechanisms of antibody-mediated immunity is crucial for developing vaccines with high efficacy. Here, we identify key roles in humoral immunity for Fcγ-receptor (FcγR) interactions and opsonic phagocytosis of sporozoites. We identify a major role for neutrophils in mediating phagocytic clearance of sporozoites in peripheral blood, whereas monocytes contribute a minor role. Antibodies also promote natural killer cell activity. Mechanistically, antibody interactions with FcγRIII appear essential, with FcγRIIa also required for maximum activity. All regions of the circumsporozoite protein are targets of functional antibodies against sporozoites, and N-terminal antibodies have more activity in some assays. Functional antibodies are slowly acquired following natural exposure to malaria, being present among some exposed adults, but uncommon among children. Our findings reveal targets and mechanisms of immunity that could be exploited in vaccine design to maximize efficacy.

Indexed as

Immunity, HumoralAdultAgedAntibodies, ProtozoanChildFemaleHumansKenyaMalariaMalaria VaccinesMaleMiddle AgedMonocytesNeutrophilsPhagocytosisPlasmodium falciparumAntibodies, ProtozoanMalaria VaccinesReceptors, IgG

Identifiers

PMID33741975
PMCPMC7979888
OpenAlexW3138924332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.